Geode Capital Management LLC Has $8.26 Million Holdings in Spok Holdings, Inc. (NASDAQ:SPOK)

Geode Capital Management LLC increased its position in shares of Spok Holdings, Inc. (NASDAQ:SPOK) by 1.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 514,427 shares of the Wireless communications provider’s stock after acquiring an additional 6,591 shares during the quarter. Geode Capital Management LLC owned 2.54% of Spok worth $8,258,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. State Street Corp raised its stake in Spok by 3.1% during the 3rd quarter. State Street Corp now owns 415,876 shares of the Wireless communications provider’s stock valued at $6,263,000 after purchasing an additional 12,467 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Spok by 7.6% during the fourth quarter. JPMorgan Chase & Co. now owns 213,575 shares of the Wireless communications provider’s stock valued at $3,428,000 after buying an additional 15,156 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Spok by 67.9% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 110,997 shares of the Wireless communications provider’s stock valued at $1,782,000 after buying an additional 44,896 shares during the period. Connor Clark & Lunn Investment Management Ltd. lifted its stake in Spok by 133.9% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 105,241 shares of the Wireless communications provider’s stock worth $1,689,000 after acquiring an additional 60,256 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. boosted its position in Spok by 33.0% during the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 50,221 shares of the Wireless communications provider’s stock worth $806,000 after acquiring an additional 12,471 shares during the period. Hedge funds and other institutional investors own 50.81% of the company’s stock.

Spok Price Performance

Shares of NASDAQ SPOK opened at $15.43 on Thursday. Spok Holdings, Inc. has a one year low of $13.24 and a one year high of $17.96. The business’s 50-day moving average price is $16.07 and its two-hundred day moving average price is $16.01. The company has a market capitalization of $315.07 million, a P/E ratio of 21.14 and a beta of 0.40.

Spok (NASDAQ:SPOK) last released its quarterly earnings data on Wednesday, February 26th. The Wireless communications provider reported $0.18 EPS for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.02). The firm had revenue of $33.89 million during the quarter, compared to analyst estimates of $35.50 million. Spok had a return on equity of 9.20% and a net margin of 10.66%. On average, equities analysts anticipate that Spok Holdings, Inc. will post 0.76 EPS for the current year.

Spok Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Friday, March 14th were issued a $0.3125 dividend. This represents a $1.25 dividend on an annualized basis and a yield of 8.10%. The ex-dividend date was Friday, March 14th. Spok’s dividend payout ratio is presently 168.92%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on SPOK. B. Riley upgraded Spok from a “neutral” rating to a “buy” rating and upped their target price for the company from $15.00 to $20.00 in a report on Thursday, February 27th. StockNews.com downgraded shares of Spok from a “strong-buy” rating to a “buy” rating in a research report on Monday.

Spok Company Profile

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.